Tenon Medical, Inc.

The momentum for this stock is not very good. Tenon Medical, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Tenon Medical, Inc..
Log in to see more information.

News

Tenon Medical Secures Funding with Preferred Stock Sale
Tenon Medical Secures Funding with Preferred Stock Sale

TipRanks Financial Blog Tenon Medical, Inc. ( ($TNON) ) has issued an update. Tenon Medical, Inc. has successfully closed a deal with investors to sell 86,454 shares of Series B Preferred ...\n more…

Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market
Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market

Accesswire ~ Interim Patient Outcomes Demonstrate Significant Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at Primary 6-month Analysis ~~ Preliminary...\n more…

Tenon Medical stock falls following 8-for-1 reverse split
Tenon Medical stock falls following 8-for-1 reverse split

Seeking Alpha - Healthcare Tenon Medical stock falls following 8-for-1 reverse split...\n more…

Tenon Medical Inc trading halted, news pending
Tenon Medical Inc trading halted, news pending

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Tenon Medical Announces 1:8 Reverse Split
Tenon Medical Announces 1:8 Reverse Split

Accesswire LOS GATOS, CA / ACCESSWIRE / September 4, 2024 / Tenon Medical, Inc. ('Tenon' or the 'Company') (NASDAQ:TNON), a company transforming care for patients suffering with certain sacroiliac joint...\n more…

Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market
Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market

Accesswire ~ Interim Patient Outcomes Demonstrate Significant Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at Primary 6-month Analysis ~~ Preliminary...\n more…